Literature DB >> 2958277

A novel adenovirus-2 E1A mRNA encoding a protein with transcription activation properties.

P J Ulfendahl1, S Linder, J P Kreivi, K Nordqvist, C Sevensson, H Hultberg, G Akusjärvi.   

Abstract

Two novel adenovirus-2 early region 1A mRNAs, designated 10S and 11S, have been characterized. They differ from the previously described 9S, 12S and 13S mRNAs by having an additional intron removed during mRNA maturation. The 10S and 11S mRNAs encode proteins with mol. wts of 30 and 35 kd. These proteins are encoded in the same translational reading frame as the 12S and 13S mRNA products and differ by lacking 72 amino acids between position 27 and 98. A functional analysis showed that both the 10S and 11S mRNA products are non-essential for lytic virus growth, and, furthermore, defective in cellular transformation. Interestingly the 11S mRNA product functioned as an efficient transcriptional activator in transient expression assays but was very ineffective as a gene activator during virus growth. Moreover, the virus expressing the 11S cDNA failed to block host cell gene expression although substantial amounts of late proteins were expressed. From the biological properties of the E1A cDNA mutants it was possible to localize two functional domains in the E1A proteins; one region required for transcriptional activation (amino acids 140-185), and a second domain required for adenovirus transformation and the control of viral and cellular gene expression during a lytic infection (amino acids 27-98).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2958277      PMCID: PMC553593          DOI: 10.1002/j.1460-2075.1987.tb02468.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  43 in total

1.  Lytic and transforming functions of individual products of the adenovirus E1A gene.

Authors:  E Moran; T Grodzicker; R J Roberts; M B Mathews; B Zerler
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

2.  Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2 alpha kinase.

Authors:  J Kitajewski; R J Schneider; B Safer; S M Munemitsu; C E Samuel; B Thimmappaya; T Shenk
Journal:  Cell       Date:  1986-04-25       Impact factor: 41.582

3.  Monoclonal antibodies specific for adenovirus early region 1A proteins: extensive heterogeneity in early region 1A products.

Authors:  E Harlow; B R Franza; C Schley
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

4.  An adenovirus early region 1A protein is required for maximal viral DNA replication in growth-arrested human cells.

Authors:  K R Spindler; C Y Eng; A J Berk
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

5.  Automatic synthesis of oligodeoxynucleotides and mixed oligodeoxynucleotides using the phosphoamidite method.

Authors:  S Josephson; E Lagerholm; G Palm
Journal:  Acta Chem Scand B       Date:  1984

6.  Anatomy of region L1 from adenovirus type 2.

Authors:  G Akusjärvi
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

7.  Adenovirus 5 early region 1A host range mutants hr3, hr4, and hr5 contain point mutations which generate single amino acid substitutions.

Authors:  G M Glenn; R P Ricciardi
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

8.  Adenovirus-2 E1A products repress enhancer-induced stimulation of transcription.

Authors:  E Borrelli; R Hen; P Chambon
Journal:  Nature       Date:  1984 Dec 13-19       Impact factor: 49.962

9.  Repression of the immunoglobulin heavy chain enhancer by the adenovirus-2 E1A products.

Authors:  R Hen; E Borrelli; P Chambon
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

10.  The release of growth arrest by microinjection of adenovirus E1A DNA.

Authors:  S Stabel; P Argos; L Philipson
Journal:  EMBO J       Date:  1985-09       Impact factor: 11.598

View more
  39 in total

1.  Identification of a bidirectional splicing enhancer: differential involvement of SR proteins in 5' or 3' splice site activation.

Authors:  C F Bourgeois; M Popielarz; G Hildwein; J Stevenin
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  Comparative sequence analysis of the largest E1A proteins of human and simian adenoviruses.

Authors:  Nikita Avvakumov; Russ Wheeler; Jean Claude D'Halluin; Joe S Mymryk
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

3.  Multiple activities of the human splicing factor ASF.

Authors:  J E Harper; J L Manley
Journal:  Gene Expr       Date:  1992

4.  Characterization of the 55-residue protein encoded by the 9S E1A mRNA of species C adenovirus.

Authors:  Matthew S Miller; Peter Pelka; Gregory J Fonseca; Michael J Cohen; Jenna N Kelly; Stephen D Barr; Roger J A Grand; Andrew S Turnell; Peter Whyte; Joe S Mymryk
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

5.  Suppression of RNA interference by adenovirus virus-associated RNA.

Authors:  M Gunnar Andersson; P C Joost Haasnoot; Ning Xu; Saideh Berenjian; Ben Berkhout; Göran Akusjärvi
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

6.  A novel protein factor is required for use of distal alternative 5' splice sites in vitro.

Authors:  J E Harper; J L Manley
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

Review 7.  Expression and interactions of human adenovirus oncoproteins.

Authors:  P A Boulanger; G E Blair
Journal:  Biochem J       Date:  1991-04-15       Impact factor: 3.857

8.  Adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins.

Authors:  E White; R Cipriani; P Sabbatini; A Denton
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

Review 9.  Intrinsic structural disorder in adenovirus E1A: a viral molecular hub linking multiple diverse processes.

Authors:  Peter Pelka; Jailal N G Ablack; Gregory J Fonseca; Ahmed F Yousef; Joe S Mymryk
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

10.  Activation in vitro of RNA polymerase II and III directed transcription by baculovirus produced E1A protein.

Authors:  G Patel; N C Jones
Journal:  Nucleic Acids Res       Date:  1990-05-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.